South Asia
Covid-19 Vaccine Nepal interested in buying Bangladeshi firm's Covid-19 vaccine
Dhaka, October 23: Nepal's Ambassador Dr. Banshidhar Mishra has expressed interest in conducting a clinical trial of a possible Covid-19 vaccine made by Bangladesh's Globe Biotech to prevent the coronavirus. He made the remarks at a press conference at Globe Pharmaceuticals' head office in Dhaka's Tejgaon on Thursday.
Dr. Banshidhar Mishra said that as a doctor, he knew the details about the vaccine called 'Bancovid' made by Globe.
"For now we are interested in getting this vaccine. If they succeed, we will be able to buy on a G2G basis. If the Bangladesh government agrees, Nepal is also interested in the clinical trial of this vaccine."
Globe Pharmaceuticals Limited Chairman Md. Harunur Rashid told a news conference that he had entered into a memorandum of understanding with a Nepali company to buy two million doses of Bancovid before it could be tested on humans.
"We have an agreement with Anmol Group of Nepal. Twenty million doses have also been ordered from several other countries. We will export only after satisfying the needs of Bangladeshis."
Globe Biotech Limited is the only Bangladeshi company in the race to develop a coronavirus vaccine whose vaccine has been included in the World Health Organization's Covid-19 vaccine candidate list.
The World Health Organization is monitoring the vaccines being developed around the world.
The World Health Organization has a list of 42 vaccines in the clinical trial stage and another list of 156 vaccines in the pre-clinical trial stage (pre-clinical trial). The list contains the names of three tickers of Globe Biotech in Bangladesh.
At a press conference at Globe Pharmaceuticals' head office in Tejgaon on July 3, Globe Biotech announced its efforts to develop a coronavirus vaccine.
Later, at another press conference on October 5, it was claimed that their possible vaccine had been shown to be "effective and completely safe" by applying it to rats.
Now they will apply to the Bangladesh Medical Research Council (BMAC) for a clinical trial.
